BiondVax Pharmaceuticals Ltd.
BVXV · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $26,898 | $102,569 | $99,813 | $261,654 |
| - Cash | $14,075 | $54,036 | $2,930 | $72,467 |
| + Debt | $21,542 | $69,737 | $20,887 | $131,283 |
| Enterprise Value | $34,365 | $118,270 | $117,771 | $320,470 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $2,748 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10,499 | -$26,761 | $5,912 | -$92,783 |
| % Margin | – | – | – | – |
| Net Income | -$531 | -$50,810 | $6,815 | -$124,112 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.2 | -36 | 6.15 | -151.98 |
| % Growth | 99.4% | -685.4% | 104% | – |
| Operating Cash Flow | -$7,265 | -$24,484 | -$72,539 | -$77,058 |
| Capital Expenditures | -$836 | -$430 | -$6,132 | -$7,429 |
| Free Cash Flow | -$8,101 | -$24,914 | -$78,671 | -$84,487 |